Beta Bionics (BBNX) leads innovation in the diabetes treatment market with its groundbreaking iLet Bionic Pancreas technology ...

Beta Bionics announced today that it went public after pricing a significantly upsized initial public offering (IPO).

Underwriters have a 30-day option to buy an additional 1.8 million shares. Beta Bionics also agreed to sell 1 million shares ...

Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its ...

Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.

The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

The iLet links an automated pump with an adaptive, closed-loop dosing algorithm, which calculates a user’s background insulin needs without them having to count their carbohydrates. Instead ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...

A penis pump can help treat erectile dysfunction (ED) by using negative air pressure to increase blood flow in the penis and create an erection. Also known as a vacuum pump or vacuum erection device, ...